Pablo Picasso againJust a note. In regular chart, previous was log. Maybe valuable, maybe not. Longby Canarytraderjoe2
$$HUMA BUYING signals? Currently, Huma is trading below its value and presents an opportunity for immediate increase in the near future. Based on the charts, a target price of $13 is suggested. Long-term holding strategy is recommended.Longby ImmaculateTony0
Humacyte, bull case.. my speculation.. If if if... Humacyte can sell 1000-3000 symvess annually Marketcap going to be 5-15billion :) Currently below 700million Im bias and huma is 30% of my stockportfolioLongby Canarytraderjoe0
Huma reverseIm Pablo picasso, and i like to draw. Just a note for myself. Maybe valuable maybe notLongby Canarytraderjoe0
Humacyte lawsuite is questionableAs a scientist, I have been in medical device development and manufacturing. Every company faces ups and downs in manufacturing medical devices. FDA regularly visits those companies for audits. As an investor, I hired and a FDA compliance expert about two weeks ago to analyze the FDA findings and decide whether I shall sell my shares. According to the expert, the FDA findings were not significant and the issues could have been fixed easily. I humbly think that Humacyte management did not own to it shareholders for disclosing such non-significant and easily fixable nuances. As such, I have been keeping my shares in the stock. My two cents on this topic. Longby getdabuzz113
They call me Pablo picassoJust some lines and indicators around this stock after pipers event that was surprisingly positive.. still DCA if drops to 3,80 after that i would own more then 3.5k shares. Im a shrimp in the space but need to start somewhereLongby Canarytraderjoe0
FDA APROVAL HUMA had a significant decline with DELAY in approval over something minor, still waiting see if it holds the 100MA and gets approval. ANALSYTS PREDICT 11$ Some insider selling and possible dilution. Watching 👀 by WSMS199Updated 3
The storyline of Humacyte.. its "imminent" We are at pessimistic phase. Insiders selling etc. That only sell 20-30% of shares after a x2-3 run up. Consilidation.. drop at delay.. no clear answer FDA... Conference calls say answer in 2025.. approval is imminent (see minds) only question.. wil we get approval after 10months(so initial time approval instead of priority) or will we hear nothing.. rumor goes away and drop till 3,20 ish zone.. where we then get a suprise in q1 2025 after few dilutions.. I still accumulating. And have a avarageprice around 4,50-5,20. Im bias and bullish. So do you own DDLongby Canarytraderjoe3
Possible breakout of HUMA with strong upside potentialDaily timeframe bull flag with strong potential for a breakout. Measured move from point of breakout puts it at possible ATH territory?!Longby Autoace10103
$HUMA - New Swing Long Trade Opportunity?NASDAQ:HUMA Hello everyone! I'm sharing both the weekly and daily charts with you. On the weekly chart (you can see below), the price tested the 100 EMA and rebounded. On the daily chart, after reaching the 30 RSI level, the price bounced back, stayed above the 100 EMA, and the UT Bot Indicator signalled a Buy. It appears the asset price has completed its correction. I’m considering a swing-long trade with a Stop Loss set at $4.60. This could be a promising swing opportunity. A new higher high from this point indicates a potential return of nearly 90%, while reaching $8 would offer a return of about 50% profit. If the price hits my stop loss, it would result in a 13% loss. With risk-to-reward ratios of 7 and 4, this represents an excellent trading opportunity. Additionally, the current market sentiment and volume trends support a bullish outlook. The asset has shown strong support at the 100 EMA, reinforcing the potential for upward movement. It's important to keep an eye on upcoming economic data releases and market events, as they could influence price action. This setup aligns well with my trading strategy, focusing on high-probability trades with favourable risk-to-reward ratios. Let's watch for a sustained breakout to maximize gains. Weekly Chart: Longby cumacevikUpdated 4419
Huma 8+ I'm long from here, golden cross on macd daily Tell me what you think. This is my first attempt Longby carnold007111
HUMA Humacyte Options Ahead of EarningsIf you haven't sold HUMA before the previous earnings: Then analyzing the options chain and the chart patterns of HUMA Humacyte prior to the earnings report this week, I would consider purchasing the 5usd strike price Calls with an expiration date of 2024-9-20, for a premium of approximately $1.22. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Longby TopgOptionsUpdated 5
HUMA Humacyte Options Ahead of EarningsAnalyzing the options chain and the chart patterns of HUMA Humacyte prior to the earnings report this week, I would consider purchasing the 5usd strike price in the money Puts with an expiration date of 2024-4-19, for a premium of approximately $1.55. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Shortby TopgOptionsUpdated 2
bearish structure at the moment 🔴needs to climb back above previous trend support before longs can see some nice upside. watching for long above 4.15, shorts below 3.06Shortby Vibranium_Capital2211
A trading genius picks the most promising small caps This is a composite of all of the picks of one of the most amazing small caps trader out there. He is wealthy and needs no fan fare. This is a snap shot of his fav picks in January.Longby TraderJoeNY113
$HUMA 911 :-)If $HUMA trades > 9.11 then there is a possibility that the shorts will want to GTFO ;-) Look at HUMAW vs HUMA. Warrants way outperforming common. Long HUMA callsLongby TraderJoeNY0